Search Results 181-190 of 30627 for Ovarian
Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302) — Mayo Clinic. · Noninvasive detection of cancer. · Gynecologic cancer ...
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ...
The Patient Advocacy Advisory Committee in the Mayo Clinic Ovarian Cancer SPORE brings together researchers and patients to improve outcomes and survival.
... ovarian cancer that responds at first to treatment with drugs that contain ... Adding abemaciclib to olaparib may work better to treat recurrent platinum- ...
The Immunometabolism and Cancer Immunology Lab of Marion R. Curtis, Ph.D., at Mayo Clinic studies the tumor microenvironment for ovarian cancer ...
Mayo Clinic researcher Carrie L. Langstraat, M.D., studies ovarian cancer outcomes and the use of AI to more accurately distinguish between cancerous and ...
Measles has long been our enemy but with modification it transforms into a weapon against ovarian cancer. Rene Maleski knew it was bad news when the young ...
The purpose of this study is to determine if long-term ovarian cancer survivors after receipt of a vaccine targeting folate receptor alpha will have persistent ...
Ovarian cancer is the most common cause of death from gynecological cancers in the U.S.. In their study, Dr. Goode and her collaborators showed that variations ...
... ovarian response to controlled ovarian stimulation in women presenting to general invitro fertilization clinics for evaluation. Participation eligibility.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.